Correlation Between XORTX Therapeutics and Context Therapeutics
Can any of the company-specific risk be diversified away by investing in both XORTX Therapeutics and Context Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining XORTX Therapeutics and Context Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between XORTX Therapeutics and Context Therapeutics, you can compare the effects of market volatilities on XORTX Therapeutics and Context Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in XORTX Therapeutics with a short position of Context Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of XORTX Therapeutics and Context Therapeutics.
Diversification Opportunities for XORTX Therapeutics and Context Therapeutics
0.73 | Correlation Coefficient |
Poor diversification
The 3 months correlation between XORTX and Context is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding XORTX Therapeutics and Context Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Context Therapeutics and XORTX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on XORTX Therapeutics are associated (or correlated) with Context Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Context Therapeutics has no effect on the direction of XORTX Therapeutics i.e., XORTX Therapeutics and Context Therapeutics go up and down completely randomly.
Pair Corralation between XORTX Therapeutics and Context Therapeutics
Given the investment horizon of 90 days XORTX Therapeutics is expected to under-perform the Context Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, XORTX Therapeutics is 1.27 times less risky than Context Therapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The Context Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 102.00 in Context Therapeutics on October 21, 2024 and sell it today you would lose (1.00) from holding Context Therapeutics or give up 0.98% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
XORTX Therapeutics vs. Context Therapeutics
Performance |
| Timeline |
| XORTX Therapeutics |
| Context Therapeutics |
XORTX Therapeutics and Context Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with XORTX Therapeutics and Context Therapeutics
The main advantage of trading using opposite XORTX Therapeutics and Context Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if XORTX Therapeutics position performs unexpectedly, Context Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Context Therapeutics will offset losses from the drop in Context Therapeutics' long position.| XORTX Therapeutics vs. Context Therapeutics | XORTX Therapeutics vs. Neurosense Therapeutics | XORTX Therapeutics vs. Quoin Pharmaceuticals Ltd | XORTX Therapeutics vs. Ensysce Biosciences |
| Context Therapeutics vs. Terns Pharmaceuticals | Context Therapeutics vs. Amylyx Pharmaceuticals | Context Therapeutics vs. Acumen Pharmaceuticals | Context Therapeutics vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |